EMERYVILLE, Calif., June 12, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, […]
Pfenex’s commercialization partner Alvogen will lead launch and commercialization efforts in the United StatesThe first FDA-approved teriparatide with Forteo® 1-3 as […]
Second Quarter Fiscal 2020 Highlights (All comparisons year-over-year unless otherwise noted)Revenues of $18.9 million, an increase of 105%, compared to $9.2 […]